-transparent.png){kind=logo}
Five patients had absence seizures refractory to treatment with either ethosuximide or valproate sodium. To determine their response to combination therapy with the two drugs, four of the five had serial 24-hour intensive monitoring studies that included cable telemetric EEG recording, closed-circuit television observation, and frequent antiepileptic drug (AED) serum level determinations. The resultant data confirmed the clinical and EEG effects of serial alterations in AED programs. All five became seizure free with combination therapy. Combination therapy with ethosuximide and valproate should be considered in patients whose absence seizures do not respond to standard therapeutic measures.
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
January 1983,
Acta neurologica Scandinavica. Supplementum,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
October 2005,
The Cochrane database of systematic reviews,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
January 2021,
The Cochrane database of systematic reviews,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
February 2017,
The Cochrane database of systematic reviews,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
January 2003,
The Cochrane database of systematic reviews,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
February 2019,
The Cochrane database of systematic reviews,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
July 1994,
Pediatric neurology,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
October 2001,
Indian journal of experimental biology,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
December 1982,
Developmental medicine and child neurology,
A J Rowan, and
J W Meijer, and
N de Beer-Pawlikowski, and
P van der Geest, and
H Meinardi
December 1988,
The Journal of pharmacology and experimental therapeutics,
